期刊文献+

HPLC法测定癃闭舒片中补骨脂素和异补骨脂素 被引量:4

Determination of psoralen and isopsoralen in Longbishu Pills by HPLC
原文传递
导出
摘要 目的建立癃闭舒片中补骨脂素和异补骨脂素的定量方法。方法对国内3个企业生产的6个批次的癃闭舒片,采用HPLC法检测,Agilent TC-C18(2)色谱柱(250 mm×4.6 mm,5μm),流动相是甲醇-水(43?57),体积流量1.0 mL/min,检测波长为246 nm,柱温30℃。结果补骨脂素回归方程为:Y=84.44X+9.994,r=0.999 9(n=12)。异补骨脂素回归方程为:Y=82.434X+8.8952,r=0.999 9(n=12)。补骨脂素和异补骨脂素的线性范围均在4.04-151.5μg。结论本方法操作简便、准确、专属性强、稳定,可用于癃闭舒片中补骨脂素和异补骨脂素的含量测定。 Objective To establish a method for the content determination of psoralen and isopsoralen in Longbishu Pills(LBSP). Methods HPLC was performed on the Agilent TC-C18(2) column(250 mm×4.6 mm, 5 μm) with the mobile phase of Me OH-H2O(43:57), the flow rate was 0.8 mL/min, the detection wavelength 246 nm, and the column temperature was 30℃. Results The element regression equation of psoralen was Y=84.44 X + 9.994, r=0.999 9(n=12). The element regression equation of isopsoralen was Y=82.434X+8.895 2, r=0.999 9(n=12). The concentrations of psoralen and isopsoralen were within the range of 4.04—151.5 μg. Conclusion The method is simple, reliable, and specific, with good reproducibility, and could be used to determine the content of psoralen and isopsoralen in Longbishu Pills.
出处 《药物评价研究》 CAS 2016年第1期97-100,共4页 Drug Evaluation Research
基金 辽宁省自然科学基金优秀人才培养项目(2015020698)
关键词 高效液相法 癃闭舒片 补骨脂素 异补骨脂素 含量测定 HPLC Longbishu Pills psoralen isopsoralen content detemination
  • 相关文献

参考文献9

二级参考文献58

共引文献135

同被引文献38

  • 1Qinhua Chen,Yuan Li,Zilin Chen Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University),Ministry of Education,and Wuhan University School of Pharmaceutical Sciences,Wuhan,430071,China.Separation,identification,and quantification of active constituents in Fructus Psoraleae by high-performance liquid chromatography with UV,ion trap mass spectrometry,and electrochemical detection[J].Journal of Pharmaceutical Analysis,2012,2(2):143-151. 被引量:7
  • 2赵忠孝,严亚锋.HPLC测定白癜风胶囊中补骨脂素、异补骨脂素的含量[J].陕西中医学院学报,2004,27(5):56-57. 被引量:4
  • 3胡学军,甄松峰,林朝展,杨金燕,祝晨蔯.补骨脂药材不同有效部位中补骨脂素和异补骨脂素的含量测定[J].中药新药与临床药理,2007,18(5):380-382. 被引量:9
  • 4国家药典委员会.中华人民共和国药典[M].北京:中国医药科技出版社,2015.
  • 5中国药典2015年版. 一部[S].2015:287.
  • 6中华人民共和国卫生部药典委员会.中华人民共和国国家中成药标准汇编口腔肿瘤儿科分册[S].北京:人民卫生出版社,2002.
  • 7Li WD, Yan CP, Wu Y, et al. Osteoblasts proliferation and differentia- tion stimulating activities of the main components of Fructus Psoraleae corylifoliae [ J ]. Phytomedicine International Journal of Phytotherapy & Phytopharmaeology,2014,21 (4) :400-405.
  • 8Kim DW, Seo KH, Curtis-Long M J, et al. Phenolic phytochemical dis- playing SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylfolia[ J]. J Enzym Inhib Med Ch,2014,29( 1 ) :59-63.
  • 9Kim YJ, Choi WI, Ko H, et al. Neobavaisoflavone sensitizes apoptosis via the inhibition of metastasis in TRAIL-resistant human glioma U373MG ceils[ J]. Life sciences ,2014,95 ( 2 ) : 101-107.
  • 10Kuete V, Sandjo LP, Kwamou GMN, et al. Activity of three cytotoxic isoflavonoids from Erythrina excelsa and Erythrina senegalensis (neobavaisoflavone, sigmoidin H and isoneorautenol) toward multi- factorial drug resistant cancer cells [ J ]. Phytomedicine, 2014,21 (5) :682-688.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部